INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

Social and economic factors may drive COVID-19 hospitalization risk more than HIV status among reproductive-age women in the Southern US.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Study of over 540,000 people suggests people with obesity are 70% more likely to be hospitalised or die from an infectious disease; people with the most severe obesity face three times the risk.

Scientists have uncovered an intriguing link between infection and brain health, finding that a common bacterium in the eye appears to be linked to cognitive decline and Alzheimer’s disease. It's the ...